06/11/2024 10:02
EQS-News: Heidelberg Pharma: Promising New Clinical Data on Lead ADC-Candidate HDP-101 to be Presented at ASH Annual Meeting 2024
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Heidelberg Pharma AG / Key words: Conference br/ Heidelberg Pharma: Promising New Clinical Data on Lead ADCCandidate HDP101 to be Presented at ASH Annual Meeting 2024... Lire...
24/10/2024 11:03
EQS-News: Heidelberg Pharma to Participate in Leading Scientific and Financial Conferences in November 2024
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Heidelberg Pharma AG / Key words: Conference br/ Heidelberg Pharma to Participate in Leading Scientific and Financial Conferences in November 2024 br/br/ 24.10.2024 /... Lire...
10/10/2024 07:06
EQS-News: Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2024
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Heidelberg Pharma AG / Key words: 9 Month figures br/ Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2024 br/br/ 10.10.2024 / 07:06... Lire...
01/10/2024 17:29
EQS-News: Heidelberg Pharma: New Clinical Data on Lead ADC Candidate HDP-101 Presented at IMS 2024 Demonstrating Complete Remission in One Patient
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Heidelberg Pharma AG / Key words: Study results br/ Heidelberg Pharma: New Clinical Data on Lead ADC Candidate HDP101 Presented at IMS 2024 Demonstrating Complete Remission in One... Lire...
01/10/2024 15:27
EQS-Adhoc: Heidelberg Pharma AG Announces Updated Guidance
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd pEQSAdhoc: Heidelberg Pharma AG / Key words: Forecastbr/ Heidelberg Pharma AG Announces Updated Guidance br/br/ 01Oct2024 / 15:27 CET/CESTbr/ Disclosure of an inside information acc. to Article 17 MAR of the... Lire...
23/09/2024 13:05
EQS-News: Heidelberg Pharma Announces New Clinical Data on Lead ATAC Candidate HDP-101 to be Presented at International Myeloma Society Annual Meeting 2024
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Heidelberg Pharma AG / Key words: Conference br/ Heidelberg Pharma Announces New Clinical Data on Lead ATAC Candidate HDP101 to be Presented at International Myeloma Society Annual... Lire...
11/07/2024 07:05
EQS-News: Heidelberg Pharma Reports on First Half-Year 2024 and the Course of Business
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Heidelberg Pharma AG / Key words: Half Year Report br/ Heidelberg Pharma Reports on First HalfYear 2024 and the Course of Business br/br/ 11.07.2024 / 07:05... Lire...
21/06/2024 11:16
EQS-News: Heidelberg Pharma reports on the results of the Annual General Meeting 2024
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Heidelberg Pharma AG / Key words: AGM/EGM br/ Heidelberg Pharma reports on the results of the Annual General Meeting 2024 br/br/ 21.06.2024 / 11:16 CET/CESTbr/ The... Lire...
18/06/2024 13:47
EQS-Adhoc: Heidelberg Pharma AG announces updated guidance
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd pEQSAdhoc: Heidelberg Pharma AG / Key words: Change in Forecastbr/ Heidelberg Pharma AG announces updated guidance br/br/ 18Jun2024 / 13:47 CET/CESTbr/ Disclosure of an inside information acc. to Article 17 MAR of... Lire...